HNRNPK and nasopharyngeal carcinoma: Notably, hnRNPK knockdown exhibited no significant impact on the chemosensitivity of NPC cells under these conditions, demonstrating that inhibiting hnRNPK expression reduced the required dosages of cisplatin while maintaining equivalent chemotherapy effects.